VWM
BBC icon

Venturi Wealth Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Venturi Wealth Management’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-44
Closed -$1.23K – 1933
2024
Q3 		$1.23K Buy
+44
New +$1.21K ﹤0.01% 1747

Other funds holding BBC

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Venturi Wealth Management's BBC Position: Q4 2024 in Review

Venturi Wealth Management sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q4 2024, closing a stake of 44 shares — an estimated $1.23K sold.

Venturi Wealth Management first reported a position in BBC in Q3 2024 and held it in 1 quarter. The position peaked at $1.23K in Q3 2024. 9 funds tracked by Wall St. Rank hold BBC as of Q4 2024.

  • Venturi Wealth Management reported no remaining Virtus Biotech Clinical Trials ETF position as of Q4 2024 after selling out during the quarter.
  • Venturi Wealth Management sold 44 Virtus Biotech Clinical Trials ETF shares in Q4 2024, an estimated $1.23K.
  • Venturi Wealth Management first reported a position in Virtus Biotech Clinical Trials ETF in Q3 2024 and held it in 1 quarter.
  • Venturi Wealth Management's Virtus Biotech Clinical Trials ETF position peaked at $1.23K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2024.

Based on Venturi Wealth Management's 13F filing for Q4 2024, filed 31 Jan 2025.